Development of a scalable process for DG-041, a potent EP3 receptor antagonist, via tandem heck reactions

Organic Process Research and Development

Volumn 11, Issue 4, 2007, Pages 747-753

  Zegar, Siead ^a   Tokar, Christopher ^a   Enache, Livia A ^a   Rajagopol, Venkat ^a   Zeller, Wayne ^a   O'Connell, Matthew ^a   Singh, Jasbir ^a   Muellner, Frank W ^a   Zembower, David E ^a  

^a DeCODE Chemistry & Biostructures   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34547854721     PISSN: 10836160     EISSN: None     Source Type: Journal    
DOI: 10.1021/op700107h     Document Type: Article

References (8)

1. Hankey, G. J.; Norman, P. E.; Eikelboom, J. W. JAMA, J. Am. Med. Assoc. 2006, 295, 547.
2. Gudmundsson, G.; Matthiasson, S. E.; Arason, H.; Johannsson, H.; Runarsson, F.; Bjarnason, H.; Helgadottir, K.; Thorisdottir, S.; Ingadottir, G.; Lindpaintner, K.; Sainz, J.; Gudnason, V.; Frigge, M. L.; Kong, A.; Gulcher, J. R.; Stefansson, K. Am. J. Hum. Genet. 2002, 70, 586.
3. Boie, Y.; Stocco, R.; Sawyer, N.; Slipetz, D. M.; Ungrin, M. D.; NeuschäferRube, F.; Püschel, G. P.; Metters, K. M.; Abramovitz, M. Eur. J. Pharmacol. 1997, 340, 227.
4. Fabre, J.-E.; Nguyen, M.; Athirakul, K.; Coggins, K.; McNeish, J. D.; Austin, S.; Parise, L. K.; FitzGerald, G. A.; Coffman, T. M.; Koller, B. H. J. Clin. Invest. 2001, 107, 603.
5. Gross, S.; Tilly, P.; Hentsch, D.; Vonesch, J.-L.; Fabre, J.-E. J. Exp. Med. 2007, 204, 311.
6. Bartoli, G.; Palmieri, G.; Bosco, M.; Dalpozzo, R. Tetrahedron Lett. 1989, 30, 2129.
7. Odle, R.; Blevins, B.; Ratcliff, M.; Hegedus, L. S. J. Org. Chem. 1980, 45, 2709.
8. Harrington, P. J.; Hegedus, L. S. J. Org. Chem. 1984, 49, 2657.